Pharma Stocks
-
Assessing Crinetics Pharmaceuticals (CRNX) Valuation After Recent Share Price Slide and Revenue Growth
Crinetics Pharmaceuticals (CRNX) shares have seen mixed movement over the past month, even as the company continues to report strong…
Read More » -
Analysts Are Updating Their Mankind Pharma Limited (NSE:MANKIND) Estimates After Its Second-Quarter Results
Last week, you might have seen that Mankind Pharma Limited (NSE:MANKIND) released its quarterly result to the market. The early…
Read More » -
Kissei Pharmaceutical (TSE:4547) Valuation in Focus After Strong H1 Results and Upgraded Outlook
Kissei Pharmaceutical (TSE:4547) shares are drawing attention after the company reported a 7.9% year-over-year jump in net sales for the…
Read More » -
Companies Like Hyloris Pharmaceuticals (EBR:HYL) Are In A Position To Invest In Growth
There’s no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com…
Read More » -
Why Neuren Pharmaceuticals (ASX:NEU) Is Down 14.6% After Revised DAYBUE Sales and Royalty Outlook
Earlier this week, Neuren Pharmaceuticals announced record Q3 2025 DAYBUE™ sales of US$101.1 million and provided an updated royalty outlook…
Read More » -
ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Strong Q3 Numbers, Stock Soars
Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 53.6% year…
Read More » -
Why Amphastar Pharmaceuticals (AMPH) Stock Is Up Today
What Happened? Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) jumped 4.9% in the afternoon session after the company reported third-quarter…
Read More » -
A Look at Royalty Pharma’s (RPRX) Valuation Following Upgraded Guidance and Buybacks
Royalty Pharma (RPRX) just raised its full-year guidance after releasing third quarter results, highlighting stronger revenue and ongoing expansion of…
Read More » -
Sun Pharma investors await clarity on US tariff after weak Q2
Sun Pharmaceutical Industries Ltd’s consolidated earnings before interest, tax, depreciation and amortization (Ebitda), adjusted for forex translation, rose a modest…
Read More » -
EyePoint Pharmaceuticals (EYPT): Is the Stock Undervalued After Recent Volatility?
EyePoint Pharmaceuticals (EYPT) has recently caught investor attention as its shares moved slightly higher, following a period of noticeable volatility.…
Read More »